Regenerative Medicine Market Analysis, Segments, Key Players JAN 18 2019 | Page 2

View more detailed TOC @
https://www.marketsandmarkets.com/Market-Reports/regenerative-medicine-market-
65442579.html
Based on therapy, the Regenerative medicine market is segmented into cell therapy, gene
therapy, tissue engineering, and immunotherapy. The cell therapy segment is expected to
account for the largest share of this market, increasing funding from several agencies and private
organizations for the research and development of cell therapies, growing inclination of the
healthcare industry towards stem cell research, and increasing global awareness about the
benefits of stem cell therapies.
By application, orthopedic & musculoskeletal disorders, dermatology, cardiology, diabetes,
central nervous system diseases, and other applications. Oncology is expected to account the
fastest growing market owing to increasing prevalence of cancer globally and rich product
pipeline and increasing demand for cancer treatments.
Request for Free Sample Report @
https://www.marketsandmarkets.com/requestsample.asp?id=65442579
Based on regions, the global Regenerative medicine market is segmented into North America,
Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for
the largest share of the market during the forecast period. Growth in this regional segment is
driven by factors such as technological advancement in the Regenerative medicine and rising
incidences of chronic diseases and aging population.
Key players in the Regenerative medicine market include Organogenesis Inc. (U.S.), Osiris
Therapeutics, Inc. (U.S.), Vericel Corporation (U.S.), Stryker Corporation (U.S.), and NuVasive, Inc.
(U.S.), Medtronic (Ireland), Acelity (KCI Concepts) (U.S.), Integra LifeSciences (U.S.), Cook Biotech
Inc. (U.S.), and C.R. Bard (U.S.).
Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting
2